In a Korean cohort of 1861 patients with nondialysis CKD, intake below 0.6 g/kg/d was linked to more kidney failure and higher all-cause mortality.
|Videos|December 2, 2021
Pharmacist Medication Insights: Parathyroid Hormone (Natpara) for Hypocalcemia
Author(s)Saro Arakelians, PharmD
Parathyroid hormone (Natpara) is indicated to control hypocalcemia in patients with hypoparathyroidism.
Advertisement
Shire’s parathyroid hormone (Natpara) is indicated to control hypocalcemia in patients with hypoparathyroidism.
The FDA approved Natpara in January 2015 as an adjunct to calcium and vitamin D therapy. The bioengineered replica of human parathyroid hormone is self-administered once a day by subcutaneous injection, and it is available in 4 dosage strengths: 25 mcg, 50 mcg, 75 mcg, and 100 mcg.
The most common side effects associated with Natpara include a tingling, tickling, or burning feeling on the skin, as well as headache and nausea.
Advertisement
Related to this article
From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
Jai Radhakrishnan, MD, MBBS, MS, FASN, discusses why IgG4-related kidney disease is often missed and what the MITIGATE subgroup data presented at ASN Kidney Week 2026 show.
Real-world data from ASN Kidney Week show GLP-1 RA users with CKD and obesity had lower rates of kidney failure, death, and heart failure exacerbation.
Hiddo J. L. Heerspink, PharmD, PhD, discusses SOLSTICE elecoglipron data, finerenone in FSGS, and glucagon’s kidney effects from ASN Kidney Week 2026.
Treated patients also had fewer post-acute hospitalizations and deaths, but individuals without risk factors saw no benefit.
A pharmacy technician reflects on 3 patient encounters that reshaped his
understanding of what a real patient requires.
A disease-modifying therapy for stage 3 T1D, a second once-weekly insulin, and automated insulin delivery for T2D mark a busy year in diabetes care.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Community Pharmacists Guide Patients New to Glucose Monitoring
2
Caitlin McClain, Peggy Lillis Foundation Board Member, Shares Her Experience With C difficile
3
Very Low Protein Intake Tied to Higher Kidney Failure Risk in CKD
4
FDA Grants Accelerated Approval to First Plasmid DNA-Based Immunotherapy for Recurrent Respiratory Papillomatosis
5